Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001658551-15-000001
Filing Date
2015-11-17
Accepted
2015-11-17 14:47:56
Documents
1
Effectiveness Date
2015-11-17
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8171
  Complete submission text file 0001658551-15-000001.txt   9215
Mailing Address 210 BROADWAY #201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY #201 CAMBRIDGE MA 02139 617-571-8872
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-251392 | Film No.: 151237972